Direct comparison
Special vs Abbreviated vs Traditional 510(k)
Compare Special, Abbreviated, and Traditional 510(k): eligibility criteria, required content, and FDA's MDUFA review-timeline goal for each pathway.
Ask about Special vs Abbreviated vs Traditional 510(k)
Answers are drawn from this comparison and the rest of the CASRAI corpus, with a link to every source.
Answers are AI-generated from CASRAI’s own published pages and can be wrong, so check the linked sources before relying on one; your question is logged without personal data — never sold, never used to train a third-party model — to show us what CASRAI is missing, so please do not type personal or confidential details. How we use this
How do Traditional 510(k), Special 510(k), Abbreviated 510(k) compare side by side?
The table below compares Traditional 510(k), Special 510(k), Abbreviated 510(k) across 6 procurement-relevant dimensions, from who can use it through if eligibility isn't met.
Side-by-side comparison
| Dimension | Traditional 510(k) | Special 510(k) | Abbreviated 510(k) |
|---|---|---|---|
| Who can use it | Any sponsor; the default pathway when neither narrower test below is met | Only the same manufacturer that holds the predicate's existing clearance | Any sponsor; no same-manufacturer restriction |
| Predicate relationship | Any legally marketed device — the sponsor's own or a competitor's | Must be the sponsor's own already-cleared device (the device being modified) | Any legally marketed device, same as Traditional |
| Core eligibility test | No special test — applies whenever Special/Abbreviated don't | Same manufacturer, unchanged intended use, unchanged fundamental technology, change assessable via the firm's own design controls | An applicable FDA guidance document, special control, or recognized consensus standard exists for the relevant performance question |
| Required content | Full substantial-equivalence comparison plus underlying performance/bench/biocompatibility/software data where the devices differ | Summary of design-control activities (risk analysis, verification/validation results) evaluating the change — not the full raw dataset | Declaration of Conformity or summary report showing conformance to the applicable guidance/standard, in place of the full underlying data |
| FDA MDUFA review goal | 90 FDA days | 30 FDA days | 90 FDA days (same as Traditional) |
| If eligibility isn't met | N/A — already the default pathway | FDA converts the submission to Traditional review and notifies the sponsor | Reverts in practice to assembling Traditional-style underlying data for the uncovered elements |
Common questions
Common questions about Traditional 510(k) vs Special 510(k) vs Abbreviated 510(k)
Can I file a Special 510(k) if my predicate is a competitor's device?
+
No. Special 510(k) eligibility requires the predicate to be the sponsor's own previously cleared device with an unchanged intended use — a competitor's device, or any change to intended use, routes the submission to Traditional or Abbreviated instead.
Does an Abbreviated 510(k) mean less FDA scrutiny?
+
No — it changes the form of the supporting evidence, not the substantial-equivalence standard. A sponsor still has to identify a predicate and establish substantial equivalence on intended use and technological characteristics; Abbreviated lets that evidence lean on a recognized standard or FDA guidance document instead of full underlying test data.
What happens if FDA disagrees a submission qualifies for the Special pathway?
+
FDA converts it to Traditional 510(k) review and notifies the sponsor, rather than rejecting the submission outright. Because that resets the review to the 90-day track, a genuinely uncertain eligibility call is worth raising with FDA through the Q-Submission program before filing.
